Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04ISG
|
||||
Former ID |
DNC005723
|
||||
Drug Name |
3-(1-Chloro-7-methoxy-naphthalen-2-yl)-pyridine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527801] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H12ClNO
|
||||
Canonical SMILES |
COC1=CC2=C(C=C1)C=CC(=C2Cl)C3=CN=CC=C3
|
||||
InChI |
1S/C16H12ClNO/c1-19-13-6-4-11-5-7-14(16(17)15(11)9-13)12-3-2-8-18-10-12/h2-10H,1H3
|
||||
InChIKey |
KRLGQBXIHBDUPS-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 17 alpha-hydroxylase-C17, 20-lyase | Target Info | Inhibitor | [527801] | |
Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [527801] | ||
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
SteroidogenesisPW000141:Steroidogenesis | |||||
WikiPathways | Metapathway biotransformation | ||||
Steroid Biosynthesis | |||||
Oxidation by Cytochrome P450 | |||||
Metabolism of steroid hormones and vitamin D | |||||
Glucocorticoid & Mineralcorticoid Metabolism | |||||
Prostate Cancer | |||||
Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation | |||||
Corticotropin-releasing hormone | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.